Non-Vegetarian Ingredient In Herbal Tooth Powder, Delhi HC Issues Notice To Patanjali Ayurveda And Baba Ramdev

New Delhi: Patanjali Ayurved Limited, led by yoga guru Ramdev, is once again under legal scrutiny as the Delhi high court has demanded responses from the Centre, the Food Safety and Standards Authority of India (FSSAI), and the company over a petition alleging misbranding of its “Divya Dant Manjan” dental care product.

The petition, filed by lawyer Yatin Sharma, claims that despite “Divya Dant Manjan” being marketed with a green dot — an indicator of vegetarian status — it actually contains “samudraphen,” a fish-derived compound.

This, according to Sharma, constitutes “misbranding” under the Drugs and Cosmetics Act. Although the law does not mandate specific labelling for drugs as vegetarian or non-vegetarian, the use of the green dot qualifies as “misbranding” under the Drugs and Cosmetics Act, the petitioner’s counsel argued.

Justice Sanjeev Narula issued notice to the Centre, the FSSAI as well as Patanjali, Divya Pharmacy, Yoga guru Ramdev and other related parties on Sharma’s petition.

The petitioner, represented by advocates Swapnil Chaudhary and Prashant Gupta, said the discovery was “distressing” for him and his family, particularly because they adhere to a strict vegetarian diet due to religious beliefs.

“Respondent No. 3 (Patanjali Ayurveda) is selling the same product with a green dot on their official website, indicating that the product is vegetarian in nature, which is contradictory.

“The Petitioner seeks redressal for the profound distress caused by the inadvertent consumption of a non-vegetarian product, emphasizing the importance of upholding religious beliefs and ensuring transparency in product representation,” the petition, filed through lawyers Mohit Solanki and Pulkit Chaudhary, stated.

The matter would be heard next in November.

Related Posts

  • Pharma
  • December 21, 2024
  • 130 views
Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Bengaluru: The Karnataka government has initiated prosecution against Paschim Banga Pharmaceuticals after five women died following C-section deliveries in Ballari district, where they were administered the company’s IV fluid. Health Minister…

  • Pharma
  • December 21, 2024
  • 192 views
NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling price fixation of 13 scheduled formulations, retail price fixation of 65 new drugs against applications from individual companies, and…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

Telangana DCA Cracks Down On Illegal Drug Practices

Telangana DCA Cracks Down On Illegal Drug Practices

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Pune: Two Arrested For Selling Illegal Steroid Injections In Gyms

Serum To Make Chikungunya Vaccine In India

Serum To Make Chikungunya Vaccine In India